Luciana Borio is a senior fellow for global health at the Council on Foreign Relations (CFR) and a venture partner at Arch, a venture capital firm supporting early-stage technology firms in IT, life sciences, and physical sciences. Dr. Borio specializes in biodefense, emerging infectious diseases, medical product development, and complex public health emergencies. From 2019 to 2021, Dr. Borio served as vice president at In-Q-Tel, an investment firm supporting the U.S. Intelligence Community. She was also the director for medical and biodefense preparedness at the National Security Council (2017-2019), coordinating responses to the Ebola epidemic, combating antimicrobial resistance, and advancing an Executive Order to modernize influenza vaccines. Earlier, she was acting chief scientist and assistant commissioner for Counterterrorism Policy at the U.S. Food and Drug Administration (2010-2017). Dr. Borio has been an adjunct assistant professor of medicine at Johns Hopkins University since 2003 and continues to practice medicine part-time. She earned her MD from George Washington University, completed her residency at New York-Presbyterian/Weill Cornell, and a fellowship in infectious diseases at Johns Hopkins, along with critical care training at the National Institutes of Health.